Switch theme
Sign up to access all valuation multiples
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
1989
504
LTM Revenue $546M
LTM EBITDA $31.0M
-$4.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Medifast has a last 12-month revenue of $546M and a last 12-month EBITDA of $31.0M.
In the most recent fiscal year, Medifast achieved revenue of $602M and an EBITDA of $15.6M.
Medifast expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Medifast valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $602M | XXX | XXX | XXX |
| Gross Profit | $1.1B | $776M | XXX | XXX | XXX |
| Gross Margin | 106% | 129% | XXX | XXX | XXX |
| EBITDA | $140M | $15.6M | XXX | XXX | XXX |
| EBITDA Margin | 13% | 3% | XXX | XXX | XXX |
| Net Profit | $144M | $99.4M | XXX | XXX | XXX |
| Net Margin | 13% | 17% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Medifast's stock price is $13.
Medifast has current market cap of $141M, and EV of -$4.9M.
See Medifast trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| -$4.9M | $141M | XXX | XXX | XXX | XXX | $1.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Medifast has market cap of $141M and EV of -$4.9M.
Medifast's trades at -0.0x LTM EV/Revenue multiple, and -0.2x LTM EBITDA.
Analysts estimate Medifast's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Medifast and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | -$4.9M | XXX | XXX | XXX |
| EV/Revenue | -0.0x | XXX | XXX | XXX |
| EV/EBITDA | -0.3x | XXX | XXX | XXX |
| P/E | 67.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -0.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMedifast's NTM/LTM revenue growth is -26%
Medifast's revenue per employee for the last fiscal year averaged $1.2M, while opex per employee averaged $0.9M for the same period.
Over next 12 months, Medifast's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Medifast's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Medifast and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -44% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 3% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -89% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -24% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.9M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 73% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Brillia Inc | XXX | XXX | XXX | XXX | XXX | XXX |
| Adore Beauty | XXX | XXX | XXX | XXX | XXX | XXX |
| Kogan.com | XXX | XXX | XXX | XXX | XXX | XXX |
| Temple & Webster | XXX | XXX | XXX | XXX | XXX | XXX |
| BIKE24 | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medifast acquired XXX companies to date.
Last acquisition by Medifast was XXXXXXXX, XXXXX XXXXX XXXXXX . Medifast acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Medifast founded? | Medifast was founded in 1989. |
| Where is Medifast headquartered? | Medifast is headquartered in United States of America. |
| How many employees does Medifast have? | As of today, Medifast has 504 employees. |
| Who is the CEO of Medifast? | Medifast's CEO is Mr. Daniel R. Chard. |
| Is Medifast publicy listed? | Yes, Medifast is a public company listed on NYS. |
| What is the stock symbol of Medifast? | Medifast trades under MED ticker. |
| When did Medifast go public? | Medifast went public in 1981. |
| Who are competitors of Medifast? | Similar companies to Medifast include e.g. Brillia Inc, Adore Beauty, Kogan.com, Temple & Webster. |
| What is the current market cap of Medifast? | Medifast's current market cap is $141M |
| What is the current revenue of Medifast? | Medifast's last 12-month revenue is $546M. |
| What is the current EBITDA of Medifast? | Medifast's last 12-month EBITDA is $31.0M. |
| What is the current EV/Revenue multiple of Medifast? | Current revenue multiple of Medifast is -0.0x. |
| What is the current EV/EBITDA multiple of Medifast? | Current EBITDA multiple of Medifast is -0.2x. |
| What is the current revenue growth of Medifast? | Medifast revenue growth between 2023 and 2024 was -44%. |
| Is Medifast profitable? | Yes, Medifast is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
